Universal STAR-T Cell Injection in R/R Autoimmune Diseases.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Immune Thrombocytopenia
Related studies linked through entity extraction aliases.
ATRA for Management of Primary ITP
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2
Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2
Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2
Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
- Status
- RECRUITING
- Phase
- PHASE1
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Status
- RECRUITING
- Phase
- PHASE2
The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Status
- RECRUITING
- Phase
- PHASE3
Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
- Status
- RECRUITING
- Phase
- PHASE2
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
- Status
- RECRUITING
- Phase
- N/A